Yoshihito Funaki

¹⁸F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease

Ryuichi Harada, Nobuyuki Okamura, Shozo Furumoto et al. · Journal of Nuclear Medicine · 2015 · 329 citations · Full text

Medicine, Neuroscience, Pharmacokinetics +17

Correlations of ¹⁸F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease

Ryuichi Harada, Aiko Ishiki, Hideaki Kai et al. · Journal of Nuclear Medicine · 2017 · 166 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Central Effects of Fexofenadine and Cetirizine: Measurement of Psychomotor Performance, Subjective Sleepiness, and Brain Histamine H₁‐Receptor Occupancy Using ¹¹C‐Doxepin Positron Emission Tomography

Manabu Tashiro, Yumiko Sakurada, Kentaro Iwabuchi et al. · The Journal of Clinical Pharmacology · 2004 · 136 citations

Medicine, Pharmacology, Pharmacotherapy +13

[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease

Ryuichi Harada, Nobuyuki Okamura, Shozo Furumoto et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 128 citations

Medicine, Neurology, Neuroscience +14

In vivo visualization of tau deposits in corticobasal syndrome by ¹⁸ F-THK5351 PET

Akio Kikuchi, Nobuyuki Okamura, Takafumi Hasegawa et al. · Neurology · 2016 · 110 citations · Full text

Life Sciences, Neurology, Neuroscience +17